Physician profile
Scott A Davis
NPI 1720034317
$6,449.47
in general payments reported to CMS, 2019-2025
33 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,289 · 2020: $476 · 2021: $849 · 2022: $1,906 · 2023: $200 · 2024: $320 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,358.17 | 2021-2022 | |
| Abiomed | $1,237.60 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,010.49 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $852.46 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $282.85 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $232.70 | 2019-2021 | |
| Angiodynamics, INC. | $187.50 | 2025 | Alphavac |
| Boston Scientific Corporation | $182.76 | 2019-2022 | |
| Abbott Laboratories | $178.56 | 2019-2025 | Cardiomems |
| Dendreon Pharmaceuticals LLC | $97.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $91.00 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $84.16 | 2021-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $63.04 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $58.78 | 2019-2022 | |
| Edwards Lifesciences Corporation | $57.44 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $55.55 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Urogen Pharma, INC. | $46.41 | 2024 | |
| Esperion Therapeutics, INC. | $40.48 | 2020 | |
| Medtronic USA, INC. | $39.86 | 2019 | |
| Irhythm Technologies, INC. | $36.18 | 2024 | Zio Xt Patch, Zio Monitor |
| Canon Medical Systems USA, INC. | $29.14 | 2019 | |
| Amarin Pharma, INC. | $26.67 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.26 | 2019-2022 | |
| Heartflow, INC. | $24.53 | 2025 | |
| Ge Healthcare | $22.01 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.46 | 2019 | |
| Atricure, INC. | $18.17 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Cardiva Medical, INC. | $17.48 | 2025 | Cardiva Vascade 6/7f Vcs |
| Lundbeck LLC | $15.92 | 2019 | |
| Bardy Diagnostics, INC. | $15.30 | 2020 | |
| Altathera Pharmaceuticals LLC | $15.24 | 2023 | Sotalol Hydrochloride |
| Lilly USA, LLC | $12.81 | 2020 | |
| Gilead Sciences, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.